In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

Eli Lilly’s experimental oral weight loss pill helped patients lose about 12 percent of their body weight on average in a late-stage trial, the company said Thursday, positive results but still ...

Lilly's late-stage results for its experimental oral obesity drug raised concerns.

Eli Lilly (NYSE:LLY) is set to release its earnings on Thursday, August 7, 2025. In the past, Eli Lilly’s stock has displayed a pattern of negative one-day returns following earnings announcements.

The Vanity Fair Oscar after-party is always a star-studded affair, and this year’s celebration at the Wallis Annenberg Center for the Performing Arts in Beverly Hills was no exception.

Lilly plans to sell its production site in Branchburg, New Jersey, as part of a broader production overhaul at the company, a spokesperson confirmed.

Alexa Bliss has been back in WWE for several months now, but fans have yet to see the full return of the twisted Bliss that took a hiatus from the company follo ...

Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to pharmaceutical companies Pfizer and Eli Lilly.

Lilly will acquire Verve Therapeutics and a pipeline of one-time treatments for cardiovascular diseases in a deal worth up to US$1.3 billion.

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin drug strategy.